Can PEPFAR expand access to sickle cell disease treatment in Africa?

For Devex, Natalie Donback, writes about barriers to the treatment of sickle cell disease (SCD) in Africa. The Access to Medicine Foundation's Research Programme Manager, James Hazel, gives his take on the issue.

"Addressing access to SCD treatment is ultimately a multistakeholder issue and larger efforts are needed."

The article highlights the Access to Medicine Index as an example of good practice that "can really help incentivise pharmaceutical companies to price their medications competitively".